HemCon Medical Technologies, a developer of lyophilized human plasma, has named Barry Starkman as the new chief executive officer (CEO). Previously, Starkman served at Promega as operational vice president, where he was responsible for ...
Tags: lyophilized human plasma, lyophilized plasma, LyP program